Modules
Wrenfield Pathology Associates, LLC
Customer 47123
- Account Classification
- End-User Laboratory
- Classification Confidence
- High
- Sites
- HQ | b45dc02a318e52b14b4f175a3d9d8dbf6155327280b266420444e7f1f45e1026
- Assigned Reps
- Marcus Feldman
- Website
- http://blockscientific.com
- Active Opportunity Count
- 2
- Published Count
- 2
- Revenue Base
- 4097.62
- Known GPBase
- 659.02
- Analyzer Platforms
- Beckman Access / DxI
- Product Groups
- Beckman Access | Other Charge Group
- Recommended Contact
- Rosa Jarrett
- Backup Contact
- Wade Lofgren | CEO & President | wade.lofgren@wrenfieldpathologyassociatesllc.com | (714) 273-9290
- Last Meaningful Activity
- 2026-07-31
- Customer Memory
- Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified item fact: storage requirement N/A. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-adb0786dbfa1c2ffe505539e9b6478059ee6b1c157d7015f5786687025cd6a28 | Customer 47123 | Item 4877 | Candidate CAND-fd947f7bd33fe893ad2a2cfe6fd15a96ff73c19158c6c42442773837e3a9bb14 | Customer 47123 | Quote 30127 | Item 14436
Opportunities (2)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quote Leakage | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fd947f7bd33fe893ad2a2cfe6fd15a96ff73c19158c6c42442773837e3a9bb14 | OPP-aecabb096371b788ca96a5276294b78a4346036a5cd75f239bf5de3b3b1e172b | SER-7f720479947345c4b7452b724832a5558f876988067fd34e94118bd6e207abc6 | Published | **** | **** | **** | Wrenfield Pathology Associates, LLC | 47123 | — | Laguna Niguel | CA | Southwest | End-User Laboratory | High | — | Other Charge Group | Misc Reagent | Bio-Rad 468 Liquichek Urine Toxicology Control, Level C2 Low Opiate | 30127 | — | Repeated Unconverted Quote on quote 30127; quote age 133 days; last modified 87 days ago; quoted value $16200.62; converted line value $0.00; unconverted line value $16200.62. | 1620.06 | 3240.12 | 4860.19 | 91.51 | 183.02 | 274.53 | 62.02 | Medium | False | False | — | RESEND_QUOTE | Candidate CAND-fd947f7bd33fe893ad2a2cfe6fd15a96ff73c19158c6c42442773837e3a9bb14 | Customer 47123 | Quote 30127 | Item 14436 |
| Cross-Sell | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-adb0786dbfa1c2ffe505539e9b6478059ee6b1c157d7015f5786687025cd6a28 | OPP-0fe9147abe27a2bfb3e01c17c42d6d7e0d0a4cb8ca9fd9b040ab7d6f47de3060 | SER-a853024b029b2130a09e4bb03b919fbcb3fd5571a3fc77e6a630b42517488b5d | Published | **** | **** | **** | Wrenfield Pathology Associates, LLC | 47123 | HQ | Laguna Niguel | CA | Southwest | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | 81906 | 81906 Beckman Access Substrate | — | — | Verified by Description for Beckman Access / DxI; item purchased by 23 of 40 comparable active sites (57.5%); peer median annual revenue $857.50. | 428.75 | 857.5 | 1286.25 | 238 | 476 | 714 | 70.96 | High | False | False | — | CONFIRM_ANALYZER | Candidate CAND-adb0786dbfa1c2ffe505539e9b6478059ee6b1c157d7015f5786687025cd6a28 | Customer 47123 | Item 4877 |